APA (7th ed.) Citation

G, M., Zhang, Z, S., J, L., Y, D., X, G., & H, C. (2026). Berberine-taxifolin co-administration attenuates inflammatory response and intestinal barrier injury via nf-κB/NLRP3 suppression in colitis. Frontiers in immunology, 16, 1725084. https://doi.org/10.3389/fimmu.2025.1725084

Chicago Style (17th ed.) Citation

G, Miao, Zhang, Sui Z, Leng J, Deng Y, Gu X, and Cao H. "Berberine-taxifolin Co-administration Attenuates Inflammatory Response and Intestinal Barrier Injury via Nf-κB/NLRP3 Suppression in Colitis." Frontiers in Immunology 16 (2026): 1725084. https://doi.org/10.3389/fimmu.2025.1725084.

MLA (9th ed.) Citation

G, Miao, et al. "Berberine-taxifolin Co-administration Attenuates Inflammatory Response and Intestinal Barrier Injury via Nf-κB/NLRP3 Suppression in Colitis." Frontiers in Immunology, vol. 16, 2026, p. 1725084, https://doi.org/10.3389/fimmu.2025.1725084.